Mohammad Atiya K, Hugtenburg Jacqueline G, Vanhommerig Joost W, van den Bemt Patricia M L A, Denig Petra, Karapinar-Carkıt Fatma
Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.
Department of Clinical Pharmacy, OLVG Hospital, Amsterdam, the Netherlands.
J Am Geriatr Soc. 2024 Dec;72(12):3681-3694. doi: 10.1111/jgs.19191. Epub 2024 Sep 20.
A prescribing cascade occurs when medication causes an adverse drug reaction (ADR) that leads to the prescription of additional medication. Prescribing cascades can cause excess medication burden, which is of particular concern in older adults. This study aims to identify and quantify potentially problematic prescribing cascades relevant for clinical practice.
A mixed-methods study was conducted. First, prescribing cascades were identified through literature search. An expert panel (n = 16) of pharmacists and physicians assessed whether these prescribing cascades were potentially problematic. Next, a cohort study quantified potentially problematic prescribing cascades in adults using Dutch community pharmacy data for the period 2015-2020. Additionally, the influence of multiple medications potentially causing the same ADR was evaluated. Prescription sequence symmetry analysis was used to calculate adjusted sequence ratios (aSRs), adjusting for temporal prescribing trends. An aSR >1.0 indicates the occurrence of a prescribing cascade. In a subgroup analysis, aSRs were calculated for older adults.
Seventy-six prescribing cascades were identified in literature and three were provided by experts. Of these, 66 (83.5%) were considered potentially problematic. A significant positive aSR for the medication sequence was found for 41 (62.1%) of these prescribing cascades. The highest aSR was found for amiodarone potentially causing hypothyroidism treated with thyroid hormones (4.63 [95% confidence interval 4.40-4.85]), based on 565 incident users. The biggest population (n = 34,645) was found for angiotensin converting enzyme-inhibitors potentially causing urinary tract infections treated with antibiotics. Regarding four potential ADRs, the aSRs were higher for people using multiple medications that cause the same ADR as compared to people using only one of those medications. Among older adults the aSRs remained significant for 37 prescribing cascades.
An overview was generated of potentially problematic prescribing cascades relevant for clinical practice. These results can support healthcare providers to intervene and reduce medication burden for older adults.
当药物引发药物不良反应(ADR)并导致开具额外药物处方时,就会发生处方级联反应。处方级联反应会导致药物负担过重,这在老年人中尤为令人担忧。本研究旨在识别和量化与临床实践相关的潜在问题处方级联反应。
进行了一项混合方法研究。首先,通过文献检索识别出处方级联反应。一个由药剂师和医生组成的专家小组(n = 16)评估这些处方级联反应是否存在潜在问题。接下来,一项队列研究使用2015 - 2020年荷兰社区药房数据量化了成年人中潜在问题处方级联反应。此外,评估了多种可能导致相同ADR的药物的影响。使用处方序列对称性分析来计算调整后的序列比(aSR),并根据时间处方趋势进行调整。aSR > 1.0表明存在处方级联反应。在亚组分析中,计算了老年人的aSR。
在文献中识别出76种处方级联反应,专家提供了3种。其中,66种(83.5%)被认为存在潜在问题。在这些处方级联反应中,41种(62.1%)的药物序列aSR呈显著正相关。基于565名新使用者,发现胺碘酮可能导致甲状腺功能减退并用甲状腺激素治疗的aSR最高(4.63 [95%置信区间4.40 - 4.85])。发现血管紧张素转换酶抑制剂可能导致用抗生素治疗的尿路感染的人群最大(n = 34,645)。对于四种潜在的ADR,与仅使用一种导致相同ADR的药物的人相比,使用多种导致相同ADR的药物的人的aSR更高。在老年人中,37种处方级联反应的aSR仍然显著。
生成了一份与临床实践相关的潜在问题处方级联反应概述。这些结果可以支持医疗保健提供者进行干预并减轻老年人的药物负担。